Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 5, 2026British Journal of Clinical PharmacologyOpen Access

Medicines, misinformation and machines: Navigating infodemics in the generative AI era

View Full Paper
Ask AI
Bookmark
Share

Authors

NMNatansh D. ModiLELisa M. Kalisch EllettMWMichael D. Wiese

Discussion

Loading...

Member takes

Overview

Policy analysis reveals risks of rapid AI-driven misinformation during health emergencies, highlighting the need for proactive regulatory infodemic triggers across digital platforms.

Key Points

  • To examine how generative artificial intelligence impacts health misinformation during emergencies and formulate a proactive regulatory model to counter inaccurate therapeutic claims.
  • Analyzed the communication risks and benefits of generative AI tools across routine health inquiries versus emergency public health scenarios.
  • Developed a two-layer governance framework separating scientific evidentiary evaluation from digital platform distribution measures.
  • Generative AI tools accelerate the production and dissemination of unverified therapeutic claims during emergencies, outpacing conventional reactive regulatory mechanisms.
  • Regulatory Infodemic Triggers provide a systematic approach to identify high-risk claims for rapid evidentiary appraisal and proportionate, time-limited digital interventions.

Cite This Study

Modi et al. (2026) studied this question.

synapsesocial.com/papers/6a9bd4536b95aff0620ebf7ehttps://doi.org/10.1002/bcp.70814
View Full Paper
Ask AI
Bookmark
Share